Skip to content

Effect of oral care on the incidence of pneumonia in acute stroke patients with different degrees of dysphagia

Effect of oral care on the incidence of pneumonia in acute stroke patients with different degrees of dysphagia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013403
Enrollment
Unknown
Registered
2017-11-15
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke associated pneumonia

Interventions

experimental group:Intensive oral care
control group:normal oral care

Sponsors

Beijing Stomatological Hospital, Capital Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) acute stroke patients; 2) can tolerate oral examination and sample collection, informed consent of patients.;Inclusion criteria: 1) acute stroke patients; 2) can tolerate oral examination and sample collection, informed consent of patients.

Exclusion criteria

Exclusion criteria: 1) patients with pneumonia at admission; 2) patients requiring mechanical ventilation; 3) patients with removable dentures; 4) allergic to chlorhexidine; 5) patients with oral tumor or acute oral infection, who received periodontal treatment in the past 3 months; 6) patients with severe liver, kidney and heart dysfunction; 7) the use of antibiotics, hormones, or other immunosuppressive agents in the past February years; 8) patients with tumors and autoimmune diseases.;Exclusion criteria: 1) patients with pneumonia at admission; 2) patients requiring mechanical ventilation; 3) patients with removable dentures; 4) allergic to chlorhexidine; 5) patients with oral tumor or acute oral infection, who received periodontal treatment in the past 3 months; 6) patients with severe liver, kidney and heart dysfunction; 7) the use of antibiotics, hormones, or other immunosuppressive agents in the past February years; 8) patients with tumors and autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Incidence of pneumonia;;Incidence of pneumonia;

Secondary

MeasureTime frame
Pathogenic bacteria of pneumonia;;Pathogenic bacteria of pneumonia;

Countries

China

Contacts

Public ContactYuan DONG;Yuan DONG ;

Beijing Stomatological Hospital, Capital Medical Hospital;Beijing Stomatological Hospital, Capital Medical Hospital

yuand_y@126.com;yuand_y@126.com+86 13811253783;+86 13811253783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026